According to the SURMOUNT-1 clinical trial, adults (overweight or obese without diabetes) taking tirzepatide 5 mg, 10 mg, and 15 mg once weekly lost an average of 16%, 21.4%, and 22.5% of their body weight, respectively, after 72 weeks
Modern consumers are increasingly skeptical of vague marketing language, and many of them want to understand the specific ingredients that make a product effective
Previously, Aetna covered the weight loss medication with restrictions, but this recent change eliminates Zepbound coverage for weight management in many of its plans, such as the Aetna Standard Plan and the Advanced Control Plan
Because of this, many people "stack" Metamucil with their shots to stay regular
What it cannot do is review your clinical history, your previous treatment experience, your current medications, or your BMI and comorbidities